Literature DB >> 29312982

Improve gut microbiome: a new horizon of cancer therapy.

Hiroshi Fukui1.   

Abstract

Entities:  

Year:  2017        PMID： 29312982      PMCID： PMC5756763          DOI： 10.21037/hbsn.2017.08.04

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

Review 1.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

2.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.

Authors:  Shin Yoshimoto; Tze Mun Loo; Koji Atarashi; Hiroaki Kanda; Seidai Sato; Seiichi Oyadomari; Yoichiro Iwakura; Kenshiro Oshima; Hidetoshi Morita; Masahira Hattori; Masahisa Hattori; Kenya Honda; Yuichi Ishikawa; Eiji Hara; Naoko Ohtani
Journal:  Nature       Date:  2013-06-26       Impact factor: 49.962

Review 3.  The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma.

Authors:  Marco Sanduzzi Zamparelli; Alba Rocco; Debora Compare; Gerardo Nardone
Journal:  United European Gastroenterol J       Date:  2017-05-08       Impact factor: 4.623

4.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

Authors:  Dianne H Dapito; Ali Mencin; Geum-Youn Gwak; Jean-Philippe Pradere; Myoung-Kuk Jang; Ingmar Mederacke; Jorge M Caviglia; Hossein Khiabanian; Adebowale Adeyemi; Ramon Bataller; Jay H Lefkowitch; Maureen Bower; Richard Friedman; R Balfour Sartor; Raul Rabadan; Robert F Schwabe
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

Review 5.  Impact of renin-angiotensin system in hepatocellular carcinoma.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Kosuke Kaji; Yosuke Aihara; Hiroshi Fukui
Journal:  Curr Cancer Drug Targets       Date:  2011-05       Impact factor: 3.428

6.  Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.

Authors:  Jun Li; Cecilia Ying Ju Sung; Nikki Lee; Yueqiong Ni; Jussi Pihlajamäki; Gianni Panagiotou; Hani El-Nezami
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

Review 7.  Taurocholic acid metabolism by gut microbes and colon cancer.

Authors:  Jason M Ridlon; Patricia G Wolf; H Rex Gaskins
Journal:  Gut Microbes       Date:  2016-03-22

8.  Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival.

Authors:  Jian-Fei Tu; Ya-Hui Ding; Xi-Hui Ying; Fa-Zong Wu; Xin-Mu Zhou; Deng-Ke Zhang; Hai Zou; Jian-Song Ji
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

9.  Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.

Authors:  Hitoshi Endo; Maki Niioka; Noriko Kobayashi; Mamoru Tanaka; Tetsu Watanabe
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

Review 10.  Gut Microbiota and Host Reaction in Liver Diseases.

Authors:  Hiroshi Fukui
Journal:  Microorganisms       Date:  2015-10-28
View more
  3 in total

1.  Alteration in gut microbiota caused by time-restricted feeding alleviate hepatic ischaemia reperfusion injury in mice.

Authors:  Jinjun Ren; Dandan Hu; Yilei Mao; Huayu Yang; Wenjun Liao; Wei Xu; Penglei Ge; Hongbing Zhang; Xinting Sang; Xin Lu; Shouxian Zhong
Journal:  J Cell Mol Med       Date:  2018-12-26       Impact factor: 5.310

Review 2.  Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

Authors:  Hiroshi Fukui
Journal:  Diseases       Date:  2019-11-12

3.  New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism.

Authors:  Xian-Wan Jiang; Ya-Ting Li; Jian-Zhong Ye; Long-Xian Lv; Li-Ya Yang; Xiao-Yuan Bian; Wen-Rui Wu; Jing-Jing Wu; Ding Shi; Qing Wang; Dai-Qiong Fang; Kai-Cen Wang; Qiang-Qiang Wang; Yan-Meng Lu; Jiao-Jiao Xie; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2020-10-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.